TITLE

Sliding scale insulin

AUTHOR(S)
Lorber, Daniel L.; Lorber, D L
PUB. DATE
November 2001
SOURCE
Diabetes Care;Nov2001, Vol. 24 Issue 11, p2011
SOURCE TYPE
Academic Journal
DOC. TYPE
commentary
ABSTRACT
Comments on an article which proposed the use of sliding scale insulin in the management of hyperglycemic crises in diabetics. Information on sliding scale insulin; Limitations.
ACCESSION #
5490703

 

Related Articles

  • Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes. Barnett, Anthony H. // Core Evidence;2011, Vol. 6 Issue 1, p67 

    Lixisenatide is a once-daily glucagon-like peptide 1 (GLP-1) receptor agonist mimicking several favorable actions of endogenous GLP-1 that result in improved glycemic control with little or no hypoglycemia and weight loss. Phase II trials have shown that lixisenatide 20 μg once daily restores...

  • Treatment intensification and blood glucose control among hospitalized diabetic patients. Matheny, Michael E.; Shubina, Maria; Kimmel, Zebadiah M.; Pendergrass, Merri L.; Turchin, Alexander // JGIM: Journal of General Internal Medicine;Feb2008, Vol. 23 Issue 2, p184 

    Background: Hyperglycemia is common among diabetic inpatients, and has been linked to adverse outcomes. However, antihyperglycemic treatment is seldom intensified in noncritical care patients, and the relationship between intensification frequency and glucose control is poorly...

  • Hypoglycemia Revisited in the Acute Care Setting. Shih-Hung Tsai; Yen-Yue Lin; Chin-Wang Hsu; Chien-Sheng Cheng; Der-Ming Chu // Yonsei Medical Journal;11/1/2011, Vol. 52 Issue 6, p898 

    Hypoglycemia is a common Finding in both daily clinical practice and acute care settings. The causes of severe hypoglycemia (SH) are multi-factorial and the major etiologies are iatrogenic, infectious diseases with sepsis and tumor or autoimmune diseases. With the advent of aggressive lowering...

  • Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes. Hollander, Priscilla A.; Blonde, Lawrence; Rowe, Richard; Mehta, Adi E.; Milburn, Joseph L.; Hershon, Kenneth S.; Chiasson, Jean-Louis; Levin, Seymour R. // Diabetes Care;Oct2004, Vol. 27 Issue 10, p2356 

    OBJECTIVE -- Glycemic control using inhaled, dry-powder insulin plus a single injection of long-acting insulin was compared with a conventional regimen in patients with type 2 diabetes, which was previously managed with at least two daily insulin injections. RESEARCH DESIGN AND METHODS --...

  • Insulin analogues have clinical and cost benefits.  // Pulse;3/15/2007, Vol. 67 Issue 10, p7 

    The article discusses a study of records from 300 general practitioner (GP) practices which found insulin glargine improved outcomes in type 2 diabetes and cut hypoglycemic events by 25% compared with insulin detemir. Glargine was compared to neutral protamine Hagedorn insulin and insulin...

  • Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients? YKI-JÄRVINEN, HANNELE; KOTRONEN], ANNA // Diabetes Care;Aug2013 Supplement, Vol. 36 Issue S2, pS205 

    The article examines research papers on the use of premixed or prandial insulin treatment regimens in insulin-naive or previously insulin-treatment patients with type 2 diabetes. The authors also examine the advantage of using premixed and basal-bolus regimens with or without oral hypoglycemic...

  • Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management. Bell, Kirstine J.; Toschi, Elena; Steil, Garry M.; Wolpert, Howard A. // Diabetes Care;Sep2016, Vol. 39 Issue 9, p1631 

    Objective: To determine insulin dose adjustments required for coverage of high-fat, high-protein (HFHP) meals in type 1 diabetes (T1D).Research Design and Methods: Ten adults with T1D received low-fat, low-protein (LFLP) and HFHP meals with identical carbohydrate...

  • Clinical Potential of Insulin Therapy in Critically Ill Patients. Mesotten, Dieter; Berghe, Greet Van den // Drugs;2003, Vol. 63 Issue 7, p625 

    Stress of critical illness is often accompanied by hyperglycaemia, whether or not the patient has a history of diabetes mellitus. This has been considered to be part of the adaptive metabolic response to stress. The level of hyperglycaemia in patients with acute myocardial infarction (MI) or...

  • Pulmonary Safety Following Discontinuation and Readministration of Inhaled Human Insulin (Exubera®) in Adults with Type 1 Diabetes. Hollander, Priscilla; Skyler, Jay; Jovanovic, Lois; Klioze, Sol; Krasner, Alan; Riese, Richard; Reis, Joann; Schwartz, Pamela // Diabetes;Jun2007 Supplement 1, Vol. 56, pA125 

    This interim analysis assessed pulmonary safety following discontinuation and readministration of Exubera® (EXU; (insulin human [rDNA origin]) Inhalation Powder) therapy in adults with type 1 diabetes mellitus (T1DM). T1DM patients (18-65 years) received EXU (n = 290) or subcutaneous insulin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics